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Abstract 
Background: Digital phenotyping promises to unobtrusively obtaining a continuous and objective input of symp‑
tomatology from patients’ daily lives. The prime example are bipolar disorders, as smartphone parameters directly 
reflect bipolar symptomatology. Empirical studies, however, have yielded inconsistent findings. We believe that three 
main shortcomings have to be addressed to fully leverage the potential of digital phenotyping: short assessment 
periods, rare outcome assessments, and an extreme fragmentation of parameters without an integrative analytical 
strategy.
Methods: To demonstrate how to overcome these shortcomings, we conducted frequent (biweekly) dimensional 
and categorical expert ratings and daily self‑ratings over an extensive assessment period (12 months) in 29 patients 
with bipolar disorder. Digital phenotypes were monitored continuously. As an integrative analytical strategy, we used 
structural equation modelling to build latent psychopathological outcomes (mania, depression) and latent digital 
phenotype predictors (sleep, activity, communicativeness).
Outcomes: Combining gold‑standard categorical expert ratings with dimensional self and expert ratings resulted in 
two latent outcomes (mania and depression) with statistically meaningful factor loadings that dynamically varied over 
299 days. Latent digital phenotypes of sleep and activity were associated with same‑day latent manic psychopathol‑
ogy, suggesting that psychopathological alterations in bipolar disorders relate to domains (latent variables of sleep 
and activity) and not only to specific behaviors (such as the number of declined incoming calls). The identification 
of latent psychopathological outcomes that dimensionally vary on a daily basis will enable to empirically determine 
which combination of digital phenotypes at which days prior to an upcoming episode are viable as digital prodromal 
predictors.
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Recently, digital phenotyping has drawn a great deal 
of attention in highly ranked journals (Tost et  al. 2019; 
Raballo 2018; Jain et al. 2015; Insel 2018), as it promises 
objective and continuous assessments of symptomatol-
ogy in patients’ daily lives (Ebner-Priemer and Santan-
gelo 2020; Trull and Ebner-Priemer 2013). According to 
some authors, digital phenotyping has even the potential 
to outperform neuroscience and genetics (Insel 2018), 
which is in line with recent claims of the WHO (World 
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Health Organization 2019) that mobile technology is the 
most promising way to reduce the global mental health 
burden. In this context, the standard prime example are 
bipolar disorders (BD), as parameters assessed via smart-
phone directly reflect bipolar symptomatology as defined 
in authoritative diagnostic manuals such as the DSM-5 
(American Psychiatric Association 2013). For exam-
ple, being more active than usual or talking quickly and 
loudly about many different things, both classification 
criteria for BD, can directly be monitored using the GPS 
sensors of the smartphone or microphone logs.
In stark contrast to these high expectations, a careful 
look into the literature (Rohani et al. 2018) reveals sub-
stantial inconsistencies. Nonreplicable findings seem to 
be the rule rather than the exception. Before going into 
detail, we want to reconsider the main concept behind 
digital phenotyping, which is obtaining information on 
psychopathological status by pure mobile sensing. To 
decide which smartphone parameters are informative, 
we need two sources of information, namely, the smart-
phone parameter (typically considered the predictor) and 
the psychopathological status/the episode (outcome). 
Both sources must be monitored over time to reveal 
meaningful variance (to “catch episodes”). In our view, 
the reported inconsistencies can be attributed to three 
main reasons: short study periods, rare outcome assess-
ments, and an extreme fragmentation of parameters.
Searching the literature for digital phenotyping stud-
ies in BD resulted in 12  weeks as the most often used 
study period (see Additional file 1). Study periods that are 
too short are problematic. However, how can we decide 
which duration is appropriate? In research on BD, this is 
quite simple. What is needed is within-subject variance 
in the psychopathological status because if patients are 
euthymic all the time, digital phenotypes cannot predict 
new episodes. Expecting new episodes within 12 weeks is 
quite gullible, but also the more advanced approaches–
6-month assessment periods (Faurholt-Jepsen et  al. 
2015a)—are limited. As they reported (Faurholt-Jepsen 
et  al. 2015b) 29  years as mean age in the BD group, a 
clinical history of four depressive and three manic epi-
sodes, the estimated chance to experience at least one ill-
ness episode in a 6-month monitoring period is less than 
40% per patient, given an estimated disorder onset age of 
20 years.
Rare outcome assessments further aggravate the 
reported issue. In the literature (see Additional file  1), 
monthly clinical ratings were the most common assess-
ment frequency. However, interviewing patients monthly 
about their depressive symptomatology using, e.g., the 
Montgomery-Asberg Depression Rating Scale (MADRS), 
does not provide continuous information over the entire 
month. It results in one depression score per month 
covering the previous four days; hence, six outcome 
assessments in a six-month study cover just 24  days. 
Symptomatology for the other 158  days is unknown. 
We illustrated this issue using our own data. Figure  1a 
depicts dimensional expert ratings covering the previous 
(in our data) three days over a 6-months study period. 
For approximately 85% of all days, no information on 
psychopathological status is available. Such a data set is 
limited in detecting the onset of a new episode. Categori-
cal expert ratings, such as structured clinical interviews 
(First et al. 2015), may be advantageous, as they cover two 
weeks instead of three/four days. However, as categorical 
ratings fix symptomatology over two weeks, the precise 
beginning of an upcoming episode and the severity of the 
episode remain unknown. This is illustrated in Fig. 1b.
The fragmentation of parameters without any integra-
tive analytical strategy  is also problematic. This is the 
case for both the predictors and the outcomes. In the lit-
erature, the number of predictors per study ranged usu-
ally between ten and 20, but only when not counting in 
thousands of used voice parameters (details see Addi-
tional file 1 ). Taking multiple outcomes within data sets 
into account (dimensional and categorical expert and 
self-ratings for mania and depression) results in hundred 
possible combinations. This not only raises questions 
about alpha-error inflation but is also meaningless in a 
clinical sense. Why should manic communicativeness 
appear more in phone calls than in text messages? Why 
should phone calls be more related to dimensional than 
to categorical expert ratings?
To achieve more consistent findings across studies, we 
call for (a) longer assessment periods to identify sufficient 
within-subject variance (“episodes”), (b) frequent and 
dimensional outcome assessments to reveal timely, accu-
rate, dimensional data indicating symptom severity and 
(c) integrative analytical strategies to reduce chance find-
ings. Thus, we conducted the BipoSense study, in which 
we collected biweekly dimensional and categorical expert 
ratings and daily self-ratings on psychopathological sta-
tus for 12 months in 29 patients with BD. In addition, we 
continuously monitored the patients’ digital phenotypes 
over 12 months by tracking various sensor outputs from 
smartphones and e-diary ratings. As an integrative ana-
lytical strategy, we used latent variables in a structural 
equation modelling (SEM). Latent variables represent 
common underlying constructs of observed indicators 
(Bollen 1989). As an oversimplification, the latent out-
come variable “mania” combines the shared variances 
of dimensional and categorical expert and self-ratings, 
resulting in one (latent) variable with dimensional values 
varying on a daily basis.
We hypothesized that (a) substantially increasing the 
study period and the temporal precision of outcomes is 
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possible, while still achieving excellent compliance, and (b) 
dimensional and categorical self- and expert ratings, on dif-
ferent time scales, can be combined to two latent psycho-
pathological outcome variables (mania and depression). 
In addition, we explored whether smartphone parameters 
can be combined into three different latent digital pheno-
type domains (activity, sleep, and communicativeness) and 
whether latent digital phenotype domains are associated 
with same-day latent psychopathological outcomes.
Methods
Study protocol & assessments (BipoSense study)
Psychopathological status
All patients were interviewed every two weeks during a 
12-month monitoring period (26 assessments per patient 
in total) and provided additional daily self-reports on 
their manic-depressive mood. In detail, a trained psychol-
ogist provided categorical and dimensional diagnostic 
instruments alternating in person at the University Hos-
pital Dresden and over the phone. Current affective epi-
sodes were determined for the previous two weeks with 
the SCID-I section A for affective episodes according to 
DSM-5 (First et  al. 2015). (Hypo)manic and depressive 
symptoms were rated with the German version of the 
Young Mania Rating Scale (YMRS) (Young et  al. 1978), 
the Bech-Rafaelsen Mania Rating Scale (BRMRS) (Bech 
et  al. 1979), and the MADRS (Montgomery and Asberg 
1979), covering the previous three days, each. Reliability 
and validity of all instruments are excellent (Montgom-
ery and Asberg 1979; Young et al. 1978; Bech et al. 1979). 
0 100 200 300
a Monthly dimensional expert ratings: MADRS
(retrospectively covering the last 3 days)
0 100 200 300
b  Monthly categorical expert ratings
(retrospectively covering the last 14 days)
0 100 200 300
c Bi-weekly dimensional expert ratings: MADRS
(retrospectively covering the last 3 days)
0 100 200 300
d  Bi-weekly categorical expert ratings
(retrospectively covering the last 14 days)
0 100 200 300
e Daily self-ratings (from depressive to manic)
0 100 200 300
f Latent factor 'depression'
Fig. 1 Outcome data (psychopathological status) from patient ID 4458 simulating common assessment strategies (a, b) and illustrating the actual 
assessment (c–e) and the derived latent outcome (f). The x‑axis represents days, and the y‑axis represents standardized values
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Furthermore, patients answered daily end-of-day diary 
questions regarding their manic-depressive mood (vis-
ual analog scale “depressed” to “elevated”; scale: 0–100), 
adapted from ChronoRecord (Bauer et al. 2012, 2008).
Digital phenotyping
We used the mobile sensing module of movisensXS to 
track various smartphone sensors (https ://www.movis 
ens.com/en/produ cts/movis ensxs /). In detail, we moni-
tored the frequency and length of incoming and outgoing 
phone calls and text messages, number of different call 
and text contacts, frequency and duration of times the 
display was on/off, rates of transmitted and received data, 
travel distances in kilometers, frequency and duration of 
different activity classes (in vehicle, on bicycle, walking, 
still, unknown, tilting) and the velocity of movement and 
number of steps. In addition, we performed end-of-day 
diaries on sleep (time spent asleep, awake or sleepless in 
bed over the previous 24 h in 60 min segments) and med-
ications (both questions adapted from ChronoRecord, an 
extensively validated electronic mood charting system) 
(Bauer et al. 2008, 2012).
The trial was approved by the IRB of the University 
Dresden (DE/EKSN38, reference number: 26012014). 
After having signed informed consent, patients received 
a study smartphone (optional) and reimbursement of 35 
€ per month.
Participants/inclusion and exclusion criteria
Patients were recruited from a specialized outpatient and 
inpatient clinic for BD at Dresden University Hospital 
and from patients who contacted the study site directly 
after seeing articles in print and online media. Out of 
the 112 patients who initially contacted our study site, 
53 patients agreed to be screened for inclusion. Finally, 
31 patients were included (e.g. 15 patients did not meet 
the inclusion criteria, 25 patients did not reply after the 
first contact, 18 patients reported living too far away, four 
patients reported technical concerns, while others did 
not provide reasons for refusal). One person prematurely 
terminated participation after three weeks due to techni-
cal reasons and one person was excluded from the data 
analysis because the specific smartphone operating sys-
tem hindered the collection of the mobile sensing data. 
The final sample consisted of 29 patients.
Inclusion criteria
(a) bipolar I and II disorders in full remission at time 
of enrolment (DSM-5: 296.46; 296.56; 296.89; YMRS 
score ≤ 12 and MADRS score ≤ 12); (b) ≥ 18  years; 
(c) ≥ three affective episodes in the last five years, includ-
ing at least one (hypo)manic episode; and (d) using a 
smartphone. Exclusion criteria: current substance use 
disorder (except for tobacco and caffeine); borderline 
personality disorder; antisocial personality disorder; 
dementia; organic brain disorders; unstable or insuffi-
ciently treated physical illnesses; clinically relevant car-
diovascular, neoplastic or cerebrovascular diseases; and 
kidney or liver disease.
Statistical analyses
Selection and modelling of latent psychopathological 
outcomes
We investigated the factor structure of the three indica-
tors for depression (daily manic-depressive mood rat-
ings, MADRS, and depressive episodes according to the 
SCID) and mania (daily manic-depressive mood ratings, 
BRMRS, YMRS, and manic episodes according to the 
SCID) using SEM (Du Toit 2008; Bollen 1989) Because 
the indicators were a mix of continuous variables and 
dichotomous variables on different time scales (current 
day, last three days, last two weeks), we decided to use a 
Bayesian estimator for these measurement models, which 
has been recommended for dichotomous dependent var-
iables in multilevel models (Asparouhov et al. 2018). We 
used the default (uninformative priors) in Mplus (Aspa-
rouhov et  al. 2018) with two chains, 10,000 iterations 
(the first half of which were discarded as burn-in) and 
a thinning factor of 300. For all analyses obtained using 
Bayesian estimators (all models involving the latent psy-
chopathological factors), parameters with 95% credible 
intervals that did not contain zero were considered sta-
tistically significant ≠ 0. For all analyses in a frequentist 
framework (all other models), statistical significance was 
determined at a level of α < 0.05.
Selection and modelling of latent digital phenotype 
predictors
In a stepwise approach, we (1) preselected indicators 
based on theoretical and conceptual considerations 
(mostly eliminating redundant variables; for details see 
Additional file 2); (2) centered all indicators on their per-
son means, and discarded variables that showed only lim-
ited variability and/or excessive skewness and/or kurtosis 
even after transformations (details in Additional file  2: 
Table  S1); and (c) examined the within-person correla-
tions using a fully saturated two-level SEM and discarded 
variables that were largely redundant (details are pro-
vided in Additional file 2: Tables S2–4).
We then conducted a multilevel confirmatory fac-
tor analysis using the remaining 13 variables: six 
indicators of activity (steps, minutes_inVehicle, min-
utes_onFoot, minutes_still, distance_travelledFast, 
distance_travelledSlowly), five indicators of com-
municativeness (phonecalls_out, phonecalls_missed, 
phonecalls_notReached, total_call_duration, 
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number_dialogue_partners), and two indicators of 
sleep (hours_asleep and wakeup_time) derived from 
the e-diary (details see Additional file 2). We estimated 
a three-factor model on the within-person level (on 
the between-person level, a fully saturated model was 
used) using Mplus 8.3 (Asparouhov et al. 2018) and the 
robust maximum likelihood estimator. One residual 
variance was estimated to be negative (number_dia-
logue_partners) and therefore set to zero. Two model 
fit indices suggested good fit (root mean square error 
of approximation [RMSEA] = 0.049, Standardized 
Root Mean Square Residual [SRMR] within = 0.054), 
while the comparative fit index [CFI] with a value 
of 0.813 was below the conventional criterion for 
adequate model fit. Modification indices suggested 
adding a residual covariance between steps and min-
utes_onFoot, which seems justified from a conceptual 
perspective, as both variables cover activity on foot. 
Adding this residual covariance improved the model fit 
substantially (RMSEA = 0.029; CFI = 0.934 and SRMR 
within = 0.044).
Role of the funding source
The study was funded by a personal university budget of 
U.E.-P. (KIT). The funding source had no involvement.
Results
Patient and monitoring characteristics of the BipoSense 
study
Patients were, on average, 44  years old (SD = 11.9), 
and 55% were female. In total, 17 were diagnosed with 
BD type I, and 12 were diagnosed with type II BD. The 
reported lifetime numbers of depressive episodes, hypo-
manic episodes and manic episodes were 7.1 (SD = 5.6), 
3.0 (SD = 3.8), and 2.8 (SD = 3.5), respectively. Patients 
participated for 356  days (SD = 15.6). Compliance was 
excellent, with rates of 97% for the biweekly diagnostic 
visits, 99% for mobile sensing data, and 89% for e-diary 
ratings. In combination with the 12-month assessment 
period, excellent compliance resulted in 299  days per 
patient (8678 days in total), including valid expert rat-
ings, e-diary ratings, and mobile sensing data. To put 
this information into context, we show the biweekly 
dimensional ratings in Fig. 1c, the biweekly categorical 
ratings in Fig. 1d, and daily self-ratings in Fig. 1e, again 
using data from patient ID4458. For the whole sample, 
39 affective episodes were diagnosed: 21 depressive 
(0.7/patient), 15 hypomanic (0.5/patient), and three 
manic (0.1/patient). According to the DSM-5 criteria 
(American Psychiatric Association 2013), patients were 
euthymic on 9509  days, depressed on 731  days, hypo-
manic on 291 days, and manic on 56 days.
Modelling latent psychopathological outcomes
We used SEM to combine dimensional and categorical 
expert and self-ratings into two latent psychopatho-
logical outcome variables, one for manic and one for 
depressive psychopathological status. The probability 
of scale reduction was 1.003 (depression) and 1.001 
(mania), indicating satisfactory model convergence. 
Table  1 lists the standardized factor loadings for both 
models; these loadings suggested that combining the 
dimensional and categorical expert and self-ratings was 
appropriate. Across both models, two patterns were 
evident. First, expert ratings showed higher factor load-
ings than the self-ratings, which means that self-ratings 
were not able to contribute as much as the expert rat-
ings. This was especially evident for mania, which 
agrees with the empirical evidence that the level of self-
awareness of manic episodes is low (Meyer et al. 2020). 
Second, the dimensional expert ratings revealed very 
high loadings, even above the categorical expert ratings 
using the DSM-5 criteria. This is not surprising, as the 
categorical, binary outcome only differentiates between 
presence vs. absence of episodes but cannot measure 
illness severity. Figure  1f illustrates the latent depres-
sion score (green line) combining all ratings into a sin-
gle-dimensional “depression” variable varying on a daily 
basis over 12  months. Daily self-ratings were coded 
from depressed to manic. Accordingly, lower values for 
self-ratings (blue line in Fig. 1e and the respective grey 
line in Fig. 1f ) correspond to higher depression values 
for expert ratings.
Table 1 Standardized factor loadings of  the  latent 
psychopathological outcome for depression (upper panel) 
and mania (lower panel)
95% credible intervals are depicted in square brackets
1 negative loadings, as high values indicate low depression
2 0 = no current depressive/manic episode; 1 = current depressive/manic 
episode
Factor loading
Latent psychopathological outcome: depression
 MADRS 0.973 [0.918; 0.998]
 Manic‑depressive  mood1 − 0.379 [− 0.411; − 0.347]
 Depr‑SCID2 0.848 [0.798; 0.895]
Latent psychopathological outcome: mania
 YMRS 0.879 [0.823; 0.932]
 BRMRS 0.908 [0.855; 0.968]
 Manic‑depressive mood 0.190 [0.146; 0.232]
 Man‑SCID2 0.589 [0.512; 0.661]
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Modelling latent digital phenotype predictors
We used multilevel SEM to model one latent digital 
phenotype predictor for each domain (sleep, activity, 
communicativeness), as depicted in Fig.  2. The overall 
model fit was acceptable (RMSEA = 0.029; CFI = 0.934 
and SRMR within = 0.044), suggesting empirical evi-
dence for the assumption of underlying common factors 
(latent variables) for the three domains. All smartphone 
parameters showed significant positive loadings on their 
respective domains, with the lowest loadings for predic-
tors with limited variance (such as missed phone calls). 
Correlations across domains were weak, suggesting that 
these three factors could be separated and contribute 
largely independent information.
Latent digital phenotype predictors related to same‑day 
latent psychopathological outcomes
Figure  3a depicts latent mania status, predicted by the 
three latent domains (zero-order predictor-outcome 
relations are explicated in Additional file 3). Day-to-day 
fluctuations in the latent mania status were associated 
with day-to-day fluctuations in activity (β = 0.123[0.075; 
0.170]), indicating that days with more activity were 
also days with higher levels of mania. Additionally, there 
was a statistically meaningful effect with regard to sleep 
(β = − 0.098[− 0.157; − 0.040]), with days with a shorter 
sleep duration and earlier end of night sleep also being 
days with higher levels of mania. Communicativeness 
had no unique effect on mania above and beyond the 
other predictors (β = − 0.012[− 0.053; 0.029]). Overall, 
the model explained 3.2% of the daily variability in mania.
Figure  3b depicts the prediction of latent depressive 
status. Daily fluctuations in latent depressive status were 
uniquely predicted by same-day activity (β = − 0.152, 
[− 0.190; − 0.113]) but not by sleep (β = − 0.022[− 0.068; 
0.025]) or communicativeness (β = 0.025[− 0.008;0.058]). 
That is, days with higher than average activity were 
days with lower depression. The three latent predictors 
together accounted for 2.2% of the within-person vari-
ability in depressive status.
Discussion
Pioneering work on digital phenotyping in BD has 
yielded inconsistent findings (Rohani et  al. 2018). This 
is not surprising, as pioneering work on other emerging 
methods has also yielded inconsistent results, such as the 
initial work on fMRI or genetics (Tam et al. 2019; Eklund 
et  al. 2016). We propose that short assessment periods, 
rare outcome assessments, and an extreme fragmentation 
of parameters without any integrative analytical strategy 
are the factors driving these inconsistencies.
We choose a 12-months study period and frequent out-
come/psychopathological assessments which resulted, in 
combination with our excellent compliance, in 299 anno-
tated days per patient, which is clearly above benchmark 
studies (Faurholt-Jepsen et  al. 2015a; Faurholt-Jepsen 
et  al. 2019). It is important to mention that sufficient 
within-subject variance is not only necessary to reveal 
significant associations, but also to prevent false positive 
findings (Button et al. 2013).
In the first analytical step, we used multilevel SEM to 
integrate the categorical expert ratings, dimensional 
expert ratings, and dimensional self-ratings at varying 
time intervals. The models converged successfully, and 
all factor loadings were statistically meaningful, suggest-
ing that it is feasible to construct latent psychopathologi-
cal outcomes by combining the gold standard categorical 
Fig. 2 Model with three latent factors for the domains of sleep, activity, and communicativeness, based on 13 smartphone parameters, showing 
within‑subject standardized factor loadings and correlations. All correlations and factor loadings are statistically significant (p < 0.001)
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expert ratings, daily dynamic information, and fluctua-
tions in severity within and between episodes.
We also integrated smartphone parameters into three 
latent domains on the predictor level (sleep, activity, 
and communicativeness). Model fits were good, indi-
cating that smartphone sensor data can meaningfully 
be combined into these three latent dimensions. In the 
last exploratory step, we successfully predicted psycho-
pathological status using the three latent digital phe-
notype predictors. Sleep and activity were statistically 
meaningfully associated with same-day manic psychopa-
thology, whereas for depression, only activity was statis-
tically significant. This suggests that psychopathological 




























PSR ≤ 1·001 b
Fig. 3 Structural model linking within‑person fluctuations in mania (a) and depression (b) to within‑person fluctuations in sleep, activity, and 
communicativeness. Figure depicts standardized estimates (with associated 95% credible intervals in square brackets). Note that only the 
within‑person associations are depicted
Page 8 of 9Ebner‑Priemer et al. Int J Bipolar Disord            (2020) 8:35 
specific behaviors, which fits nicely to current authorita-
tive systems (American Psychiatric Association 2013). 
Translated into clinical practice, this denotes, that com-
municativeness in general is altered in patients with 
BD, not only specific parameters, such as the number of 
declined incoming calls.
In both models (mania, depression), the explained 
variance was modest, namely, 3.2% and 2.2%, respec-
tively. Unfortunately, previous papers rarely reported the 
amount of explained variance, but in those that did, the 
amounts were comparable (Gershon et al. 2016). There-
fore, our findings are in line with the mixed and contra-
dictory findings of earlier studies (Rohani et al. 2018) and 
recent randomized controlled trials (RCTs) (Faurholt-
Jepsen et  al. 2015a,2019). However, the generation of 
a solid data set, covering daily fluctuations in symptom 
severity, enables to empirically determine: (a) which tem-
poral resolution yields the most reliable estimates, (b) 
which combination of digital phenotypes best predict 
psychopathology (“three out of seven” similar to classifi-
cation systems (American Psychiatric Association 2013), 
(c) which parameters to integrate as digital phenotypes 
(given the relation between daily mood ratings and the 
latent outcome depression in Table 1 might push the idea 
to use daily mood ratings as digital phenotyping predic-
tor, which would translate to 15.5% explained variance 
for depression), (d) whether there are nonlinear rela-
tions, and (e) how to use individualized prediction mod-
els to enable the personalization of medicine (Fisher and 
Boswell 2016).
Although our study did address preexisting shortcom-
ings, some remaining limitations must be noted. First, 
even though our data set likely has the most labelled 
days/patient, and although we only included patients 
with a high number of previous episodes, the actual num-
ber of upcoming episodes was still limited (0.7 depres-
sive episodes/patient; 0.6 (hypo)manic episodes/patient). 
Simulation studies are needed to estimate if within-sub-
ject variance (i.e., few episodes) can be compensated for 
by number of participants. For treatment studies focused 
on preventing new episodes, even longer study durations 
might be warranted, such as 18 months in our currently 
running RCT (Mühlbauer et al. 2018). Second, it has been 
speculated that frequent assessments of psychopatholog-
ical status might hinder new episodes. With our biweekly 
interviews and daily ratings, our design maximizes this 
issue. However, we diagnosed more upcoming affective 
episodes during the 12-month assessment than expected 
according to the patients’ lifetime histories (estimated 0.3 
depressive, 0.1 hypomanic, and 0.1 manic episodes per 
year and participant, assuming an onset at age 20). Third, 
we argued that latent constructs should result in more 
reliable estimates, solving the problem of replication. 
Even though the model fits were convincing, additional 
studies are needed to replicate the reported factor struc-
ture. Fourth, as in other studies (Faurholt-Jepsen et  al. 
2015b, 2019; Gershon et  al. 2016; Palmius et  al. 2017), 
the selection of parameters was, at least to some extent, 
based on technology. That is, we used parameters that 
were easy to track with mobile sensing. Future studies 
might explore more specific symptoms (such as the fluid-
ity of communication or volume of speech).
To fully leverage the potential of digital phenotyping, 
we recommend the future studies do the following:
– Ensure sufficient within-subject variance in psycho-
pathological status (patients without manic/depres-
sive episodes do not contribute as much).
– Maximize the number of labelled days.
– Increase the temporal accuracy of the psychopatho-
logical status (having precise data on which days the 
episode began and ended improves the prediction).
– Design a measurement model that includes the 
severity of psychopathology (with more than pres-
ence or absence of an episode).
– Develop measurement models to integrate frag-
mented variables, thereby limiting the inflation of 
chance (e.g. using latent variables).
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